Literature DB >> 8984739

The ligand binding site of the angiotensin AT1 receptor.

L Hunyady1, T Balla, K J Catt.   

Abstract

The angiotensin AT1 receptor mediates numerous physiological actions of the octapeptide hormone, angiotensin II, in its cardiovascular and other target tissues. The binding of angiotensin II to the AT1 receptor is dependent on both intramembrane and extracellular regions of the receptor molecule. Non-peptide antagonists that block angiotensin binding and action interact exclusively with residues located within the intramembrane binding pocket of the AT1 receptor. However, peptide ligands also interact with extracellular residues to form additional bonds that stabilize their binding to the receptor. Here, László Hunyady, Tamás Balla and Kevin Catt describe how these and other studies have shown that interaction of ligands with residues in the intramembrane binding pocket is the conserved mechanism required for agonist activation of G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8984739     DOI: 10.1016/0165-6147(96)81588-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  11 in total

1.  Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Authors:  J Sun; J A Ember; T H Chao; Y Fukuoka; R D Ye; T E Hugli
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Modes of peptide binding in G protein-coupled receptors.

Authors:  M Berthold; T Bartfai
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

4.  Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart.

Authors:  S Takeo; Y Nasa; K Tanonaka; F Yamaguchi; K Yabe; H Hayashi; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

5.  Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle.

Authors:  E Mascareno; M Dhar; M A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

6.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

Authors:  W K Wang; T Dudek; Y J Zhao; H G Brumblay; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.

Authors:  B Deslauriers; C Ponce; C Lombard; R Larguier; J C Bonnafous; J Marie
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

8.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

9.  Bidirectional modulation of exocytosis by angiotensin II involves multiple G-protein-regulated transduction pathways in chromaffin cells.

Authors:  A G Teschemacher; E P Seward
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

10.  Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion.

Authors:  Dinender Kumar; Vijayan Menon; William R Ford; Alexander S Clanachan; Bodh I Jugdutt
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.